Lecture 2 olympics Flashcards

1
Q

a patient who is newly diagnosed with Parkinson disease is prescribed levodopa. The patient asks the nurse about drugs to prevent disease progression. What will the nurse tell this patient.

A

“While some drugs show promise, there are no studies that have proven a neuroprotective effect”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

A hospitalized patient with parkinson disease who is receiving apomorphine to treat “off” episodes develops nausea and vomiting. The nurse will discuss the use of which medication with the patient’s provider?

A

Trimethobenzamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What point should be included when teaching a patient about the use of apomorphine for treatment of Parkinson’s disease

A

-Apomorphine does not have any opioid activity
-A multidose injector pen is commonly used to administer apomorphine.
- You may experience nausea and vomiting, which can be treated with trimethobenzamide
-you may experience sleep attacks or episodes of daytime sleepiness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A patient has taken levodopa for parkinson. disease for 2 weeks but reports no improvement in the symptoms. Which response by the nurse is correct?

A

“It may take several months for a response to occur’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the pharmacologic action of entacapone, a potent catechol O methyl transferase (COMT) inhibitor?

A

Reduces the destruction of dopamine in peripheral tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

A patient with Parkinson disease is taking levodopa/carbidopa and reports occasional periods of loss of drug effect lasting from minutes to several hours. The nurse questions the patient further and discovers that these episodes occur at different times related to the medication administration.The nurse will contact the provider to discuss :

A

administering a catechol-O-methyltransferase (COMT) inhibitor, such as entacapone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which neurotransmitter has an inhibitory action within the central nervous system?

A

Gamma-aminobutyric acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The nurse is providing information to a patient recently prescribed entacapone. Which statement is correct ?

A

Dosage is adjusted according to the patient’s response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The nurse is assessing an older patient with Parkinson’s disease who was startedon entacapone 1 week ago. The patient has a history of coronary artery disease and takes an antihypertensive and aspirin. Which information would support the need for a reduction in medication dosage by the health care provider?

A

dizziness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which symptoms in a patient taking levodopa for Parkinson disease indicate the drug is “wearing off”

A

-difficulty swallowing
-increased tremors
-slower gait

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

A nurse provides teaching for a patient who is newly diagnosed with Parkinson disease. Which statement by the patient indicates understanding of the drug therapy for this disease ?

A

“A levodopa/carbidopa combination is used to improve motor function”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

A nursing student wants to know how carbidopa can be effective for treating Parkinson disease if it prevents the conversion of levodopa to dopamine. the nurse explains that carbidopa:

A

does not cross the blood-brain barrier

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

A patient newly diagnosed with Parkinson disease is prescribed an oral dopamine agonist. Which precaution is most important to teach the patient and family about the timing for taking this drug?

A

“Take the drug 30 to 60 min before meals on an empty stomach”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The nurse provides teaching for a patient who will begin taking rotigotine to treat Parkinson disease. What will the nurse include in teaching?

A

“if you need to stop this drug, your provider will order a gradual withdrawal”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

A patient has been diagnosed with Parkinson disease and begins treatment with levodopa/carbidopa. After several monthsof therapy, the patient reports no change in symptoms. The nurse will expect the provider to:

A

re-evaluate the diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

A patient who has begun taking levodopa/carbidopa reports feeling lightheaded and dizzy, especially when standing up from a sitting position. What will the nurse recommend?

A

Increasing salt and water intake

17
Q

Which adverse effects associated with levodopa therapy would support thee nursing diagnosis Risk for injury ?

A

Orthostatic hypotension

18
Q

A nurse is discussing motor symptoms with a patient with Parkinson disease who has been taking levodopa/carbidopa for 9 months and who is now having regular tics. Which statement by the patient indicates understanding of this symptom?

A

” I may need to try a lower dose of Sinemet to reduce my tics”

19
Q

A patient newly diagnosed with Parkinson disease has been taking levodopa/carbidopa for several weeks and complains of nausea and vomitting. The nurse tells the patient to discuss what with the provider?

A

Taking a lower dose with a low-protein snack

20
Q

A nursing student. wants to know why a patient who has been taking levodopa for years will now receive levodopa/carbidopa. The nurse explains the reasons that levodopa as a single agent is no longer available. Which statement by the student indicates a need for further education?

A

“Combination products cause fewer dyskiniesias and decreased psychosis

20
Q

Why are carbidopa and levodopa usually given together?

A

Carbidopa enhances the action of levodopa, and less drug is needed

21
Q

How does the drug tolcapone relieve symptoms of Parkinson disease

A

Suppresses the activity of an enzyme that normally breaks down naturally occurring dopamine

22
Q

A patient with Parkinson disease is taking levodopa/carbidopa along with amantadine 400 mg/day to treat dyskinesias. The patient reports having increased dyskinesias several months after beginning the amantadine. The nurse will contact the provider to discuss which action?

A

Interrupting treatment with amantadine for several weeks

22
Q

The nurse is teaching a patient with Parkinson’s disease about levodopa. Which statement by the nurse is accurate regarding drug administration?

A

“take this medication with food or antacids to reduce GI upset”

23
Q

The nurse is preparing to begin administration of apomorphine to a patient. Before administering, the nurse will perform a baseline assessment of the patient’s :

A

-mobility
-orientation
-alertness
-vital signs

24
Q

When assessing a patient with Parkinson disease who takes a carbidopa/levodopa combination drug, you find that he now has almost constant muscle movements that look like uncoordinated dancing. What is your best action ?

A

Hold the next drug dose and report the finding to the healthcare provider.

25
Q

A nurse is teaching a group of nurses about Parkinson medications. The nurse is correct to state that one side effect associated with pramipexole that is less likely to occur with other dopamine agonists is :

A

sleep attacks

26
Q

Parkinson’s disease has which characteristic symptoms :

A

-muscle tremors
-posture alterations
-slow body movement

27
Q

What is the rationale for administering levodopa instead of dopamine for treatment of Parkinson’s disease ?

A

Dopamine does not cross the blood-brain barrier when administered orally

28
Q

A patient with Parkinson disease is taking levodopa/carbidopa. The prescriber orders bromocriptine to treat dyskinesias. The nurse notes that the patient is agitated, and the patient reports having frequent nightmares. The nurse will contact the provider to discuss

A

reducing the dose of bromocriptine

29
Q

Which cholinergic symptoms of Parkinson’s disease are reduced with anticholinergic drugs

A

tremors and drooling

30
Q

Dopamine agonists have been linked with which adverse effects in patients with Parkinson’s disease

A

Sudden sleep events

31
Q

A patient taking rasagiline is assessed by the nurse to have a lasting significant increase in blood pressure. When reviewing the patient’s current list of medications, the nurse decides to hold the next dose of :

A

ciprofloxacin

32
Q

When a patient taking a monoamine oxidase B inhibitor receives his dietary tray, the nurse knows to remove the :

A

cheese

33
Q

The nurse is providing education to a patient recently placed on selegiline disintegrating tablets. Which statement by the patient indicates a need for further teaching ?

A

“I will place the tablet on my tongue before breakfast”

34
Q

Which vitamin will reduce the therapeutic effects of levodopa?

A

B6